Log in

Relevant bibliographies by topics / Jean Jansem

Academic literature on the topic 'Jean Jansem'

Author: Grafiati

Published: 22 June 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Jean Jansem.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Journal articles on the topic "Jean Jansem":

1

Sénina (nonne Kassia), Tatiana A. "Sur l’origine des sobriquets de Jean le Grammairien « Jannes » et « Sorcier »." Scrinium 12, no. 1 (November 17, 2016): 322–28. http://dx.doi.org/10.1163/18177565-00121p18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

The nickname “Jannes” given by iconodules to the last iconoclastic patriarsh John the Grammarian sprang up already in 814–815. It was based on 2 Tim 3:8 and probably on an apocryphal work about the magicians Jannes and Jambres. Initially this nickname implied anything but John’s “corrupt mind.” As to the charges of sorcery against John and to the nickname “Sorcerer,” this is a result of the subsequent comprehension of the same sources and possibly of rumors about semi-occult experiment performed by John.

2

Stamm, Irmgard. "»Die Revolution verschlingt ihre Kinder« – Jean Jansen aus Köln, erschossen in Rastatt 1849." Jahrbuch des Kölnischen Geschichtsvereins 82-83, no. 1 (November 2015): 223–34. http://dx.doi.org/10.7788/jbkgv-2015-0106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

SAVARD, Pierre. "Du lac Saint-Jean au Texas : Claudio Jannet à la recherche de l'Amérique idéale." Revue française d'histoire d'outre-mer 77, no. 288 (1990): 3–19. http://dx.doi.org/10.3406/outre.1990.2811.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Huang, Zhangzan, Noor Wortelboer, Corine Beaufort, Seda N. Ortak, Da-wei Chan, Hamit H. Dag, Jean Helmijr, John Martens, and Maurice Jansen. "Abstract 3282: Endocrine resistance genes driving cross-resistance to current combination therapies in HR-positive breast cancer." Cancer Research 84, no. 6_Supplement (March 22, 2024): 3282. http://dx.doi.org/10.1158/1538-7445.am2024-3282.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Abstract Introduction: Treatment failure to multiple treatment lines in hormone receptor positive (HR+) patients brings cross-resistance into the stage. The study aimed to determine if tamoxifen resistance genes cause cross-resistance to commonly employed metastatic breast cancer (combination) treatments. Materials & Methods: Parental and tamoxifen resistant MCF7A models (BCAR3, BCAR4, EGFR, AKT1 and AKT2) were cultured for 10 days with different concentrations of tamoxifen and fulvestrant (endocrine therapy), ribo-, abema-, and palbociclib (CDK4/6 inhibitors) and alpelisib (PIK3CA inhibitor). Compounds were tested as mono- and combination therapy in replicate experiments estimating cell growth using the Sulforhodamine B assay and half maximal inhibitory concentration (IC50) was calculated by Graphpad PRISM v5 software. Resistance was declared when IC50 was significantly different from parental (p<0.05, Mann-Whitney U test). Results: The BCAR3, BCAR4 and EGFR models were not only resistant to tamoxifen but also to fulvestrant monotherapy (see table). In the two AKTs models the initial results could not be reproduced and were excluded from the study. The BCAR4 model was also resistant to all CDK4/6- and PIK3CA-inhibitors monotherapy. Analysis of the combination regimens demonstrated cross-resistance in the BCAR4 model for all compound combinations tested, in the EGFR model for all combinations except fulvestrant combined with alpelisib, and in the BCAR3 model only for tamoxifen combined with alpelisib. Discussion/Conclusion: Tamoxifen resistance genes BCAR3, BCAR4 and EGFR show various degrees of cross-resistance to other breast cancer treatments. It might be worthwhile to evaluate these genes or their associated biological pathways as predictive biomarkers for cross-resistance in HR+ breast cancer patients treated with the mentioned (combination) therapies. Summary of median IC50 (IQR) for different conditions parental BCAR3 BCAR4 EGFR AKT1 AKT2 Monotherapy Tamoxifen 9.8 (7.0) 47.3 (121) ** 2210 (1280) ** 515 (495) ** 8.0 (21.3) 3.8 (21.8) Fulvestrant 0.1 (0.35) 0.8 (0.8) ** 309 (407) ** 11.4 (37.7) ** Ribociclib 479 (285) 423 (1102) 3099 (1212)** 719 (669) Abemaciclib 94.9 (82.5) 28.9 (52.6) 206 (197) * 189 (172) Palbociclib 138 (163) 91.1 (107) 608 (347) ** 158 (128) Alpelisib 14.1 (676) 322 (94.0) 1424 (372) ** 375 (356) Combination therapy Tamoxifen with Ribociclib 1.7 (1.0) 17.2 (29.0) 111 (159) * 54.4 (35.8) * Abemaciclib 2.5 (1.9) 6.0 (10.7) 19.5 (15.0) ** 40.0 (53.6) * Palbociclib 1.6 (2.0) 5.4 (4.6) 74.9 (80.9) * 29.2 (3.1) * Alpelisib 2.1 (0.3) 9.6 (12.4)* 157 (69.9) * 17.8 (9.9) * Combination therapy Fulvestrant with Ribociclib 0.07 (0.02) 0.1 (0.3) 14.4 (8.8) * 6.9(16.8) * Abemaciclib 0.07 (0.02) 0.1 (0.1) 4.6 (2.6) ** 2.6 (6.5) * Palbociclib 0.2 (0.1) 0.2 (1.6) 5.6 (0.9) * 1.3 (1.5) * Alpelisib 0.05 (0.05) 1.6 (20.6) 13.3 (8.1) * 2.1 (0.9) *:p<0.05, **:p<0.01 compared to parental cell line. Citation Format: Zhangzan Huang, Noor Wortelboer, Corine Beaufort, Seda N. Ortak, Da-wei Chan, Hamit H. Dag, Jean Helmijr, John Martens, Maurice Jansen. Endocrine resistance genes driving cross-resistance to current combination therapies in HR-positive breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3282.

5

Choquette, D., L. Bessette, L. Choquette Sauvageau, J. Brown, I. Ferdinand, P. Haraoui, M. Joly-Chevrier, et al. "POS0057 WHICH ADVANCED TREATMENT SHOULD BE USED FOLLOWING THE FAILURE OF A FIRST-LINE ANTI-TNF IN PATIENTS WITH RHEUMATOID ARTHRITIS? 15 YEARS OF EVIDENCE FROM THE QUEBEC REGISTRY RHUMADATA™." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 239.1–239. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1423.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

BackgroundSince 2000, advanced therapies (AT) have revolutionized rheumatoid arthritis (RA) treatment. Initially, TNF-targeted therapies were the only options. Then, therapies with different modes of action (OMA) appeared. Habits and medication availability often determine second-line AT choices. Research suggests that specific sequences provide better long-term effectiveness [1,2].ObjectivesEvaluate which alternative medication provides the best sustainability following first-line TNF failure.MethodsData from AT prescribed since January 2007 was extracted from RHUMADATA™. Patients were followed until treatment discontinuation, loss to follow-up, or November 25, 2022. A descriptive statistic was used to compare patient characteristics. Kaplan-Meier was used to compare treatment discontinuation rates.ResultsA total of 611 patients (320 TNFi and 291 1237 OMA were included. The mean age at diagnosis was 44.5 (14.4) and 43.9 (14.8) in the TNFi and OMA groups, and disease duration at treatment initiation (TI) was 14.1 (11.1) and 12.9 (12.9). Women made up 72.8% and 81.1% of these groups. The age-adjusted Charlson Comorbidity index (ACCI) was 2.15 (1.7) and 2.1 (1.7). Patients reported more comorbidities, pain and fatigue, longer duration of morning stiffness, and higher HAQ score and disease activity in the OMA group (Table 1). The physician’s global assessment of disease activity and the number of swollen and tender joints were also higher in the OMA group. OMAs retention was higher (Figure 1, logrank=0.0134) than TNFi retention following initial TNFi-IR. In a stratified analysis, rituximab (adjusted (Sidak) logrank=0.0048) had higher retention.ConclusionWhen a first TNFi fails, switching to an OMA, especially rituximab, appears to be the best strategy. Adequate assessment of more recent agents require longer observation periods.References[1]Choquette, D., Bessette, L., Alemao, E.et al. Arthritis Res Ther21, 138 (2019).[2]Lopatina E, Marshall DA, Coupal L, Le Lorier J, Choquette D. Curr Med Res Opin. 2021 Jan;37(1):157-166.Table 1.Characteristics of selected patients at TIVariableOMA (N=291)TNFi (N=320)P-ValueAge at diagnosis, years43.9 ± 14.8 (N=291)44.5 ± 14.4 (N=320)0.6324¹Disease duration at TI, years12.9 ± 10.4 (N=291)14.1 ± 11.1 (N=320)0.1741¹Women, n (%)236 (81.1%)233 (72.8%)0.0166²ACCI2.1 ± 1.7 (N=291)2.1 ± 1.7 (N=320)0.9498¹Hyperlipidemia3118 (40.6%)126 (39.4%)0.8042²Diabetes355 (18.9%)48 (15.0%)0.2340²Hypertension3160 (55.0%)171 (53.4%)0.7452²COPD3113 (38.8%)102 (31.9%)0.0755²CVD353 (18.2%)48 (15.0%)0.3265²Patient global, 1 to 10 visual analog scale [VAS]5.3 ± 2.6 (N=200)4.0 ± 2.8 (N=176)<.0001¹Patient pain, VAS5.8 ± 2.8 (N=200)4.3 ± 3.0 (N=176)<.0001¹Patient fatigue, VAS5.5 ± 2.9 (N=200)4.1 ± 3.2 (N=176)<.0001¹Duration of morning stiffness, minutes124.6 ± 284.1 (N=201)71.7 ± 215.7 (N=175)0.0451¹HAQ score1.4 ± 0.6 (N=202)1.1 ± 0.7 (N=176)<.0001¹Physician global assessment, VAS4.6 ± 2.7 (N=138)2.9 ± 2.5 (N=121)<.0001¹Swollen joint count,/28 joints8.0 ± 5.2 (N=165)4.9 ± 6.0 (N=142)<.0001¹Tender joint count,/28 joints7.2 ± 6.0 (N=165)4.3 ± 5.6 (N=142)<.0001¹RF, ever positive194 (69.8%)200 (65.4%)0.2887²ACPA, ever positive168 (62.9%)168 (61.1%)0.7234²ESR at TI, mm/hr26.9 ± 23.5 (N=211)21.6 ± 18.2 (N=183)0.0136¹CRP at TI, mg/L15.4 ± 23.0 (N=224)8.9 ± 14.4 (N=211)0.0005¹Continuous data are presented as mean ± standard deviation (N=X), where X represents the number of non-missing data points, and categorical data are expressed as n (%). P-values are based on1pooled variance t-test or2Fisher’s exact tests.3The presence of comorbidity is based on an established diagnosis and/or comorbidity-specific drug use.Figure 1.Acknowledgements:NIL.Disclosure of InterestsDenis Choquette Speakers bureau: Abbvie, Amgen, Eli Lilly, Fresenius Kabi, Novartis, Pfizer, Sandoz, Tevepharm, Consultant of: Abbvie, Amgen, Eli Lilly, Fresenius Kabi, Novartis, Pfizer, Sandoz, Tevepharm, Grant/research support from: Abbvie, Amgen, Eli Lilly, Fresenius Kabi, Novartis, Pfizer, Sandoz, Tevepharm, Louis Bessette Speakers bureau: Abbvie, Amgen, BMS, Eli Lilly, Fresenius Kabi, Janssen, Novartis, Pfizer, Sandoz, Tevepharm, UCB, Consultant of: Abbvie, Amgen, BMS, Celgene, Eli Lilly, Fresenius Kabi, Janssen, Novartis, Pfizer, Sandoz, Sanofi-Genzyme, Tevepharm, UCB, Grant/research support from: Abbvie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, Roche, Sandoz, Sanofi-Genzyme, UCB, Loïc Choquette Sauvageau: None declared, Jacques Brown Speakers bureau: Amgen, Janssen, Consultant of: Amgen, Gilead, Paladin, Pfizer, Ultragenyx, Isabelle Ferdinand Speakers bureau: Pfizer, Consultant of: Abbvie, Eli Lilly, Fresenius Kabi, Janssen, Novartis, Pfizer, UCB, Paul Haraoui Speakers bureau: Pfizer, Consultant of: Abbvie, Amgen, Lilly, Pfizer, Sandoz, UCB, Grant/research support from: Abbvie, Amgen, Pfizer, UCB, Maxine Joly-Chevrier: None declared, Ariel Masetto Speakers bureau: Abbvie, Janssen, Novartis, Pfizer, Consultant of: Abbvie, Janssen, Novartis, Pfizer, Sanofi-Genzyme, UCB, Grant/research support from: Novartis, Frédéric Massicotte Speakers bureau: Jansen, Consultant of: Abbvie, Eli Lilly, Janssen, Pfizer, Valerie Nadon Consultant of: Abbvie, Eli Lilly, Janssen, Pfizer, Roche, Sanofi-Genzyme, Jean-Pierre Pelletier Shareholder of: ArthroLab Inc., Consultant of: TRB Chemedica SA, Grant/research support from: TRB Chemedica SA, Jean-Pierre Raynauld Speakers bureau: Abbvie, Amgen, BMS, Eli Lilly, Janssen, Novartis, Pfizer, Sandoz, Sanofi-Genzyme, Consultant of: Abbvie, ArthroLab Inc., Janssen, Pfizer, Sanofi-Genzyme, Diane Sauvageau: None declared, Angèle Turcotte: None declared, Édith Villeneuve Speakers bureau: Abbvie, BMS, Novartis, Pfizer, Consultant of: Abbvie, Amgen, Novartis, Pfizer, Louis Coupal: None declared.

6

Pendergrass, Jan. "André Janier. Les Serées (1584–1597–1598) du librarie-imprimeur Guillaume Bouchet (1514–1594). Bibliothèque littéraire de la Renaissance 61. Ed. Jean-Claude Arnould. Paris : Honoré Champion Éditeur, 2006. 1040 pp. index. append. illus. tbls. bibl. 荤160. ISBN: 978-2-7453-1169-6." Renaissance Quarterly 60, no. 4 (2007): 1356–58. http://dx.doi.org/10.1353/ren.2007.0346.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kantor, Elizabeth D., Kelli O’Connell, Isaac J. Ergas, Emily Valice, Janise M. Roh, Jenna Bhimani, Narre Heon, et al. "Abstract P3-03-09: Assessment of Breast Cancer Chemotherapy Dose Reduction in an Integrated Healthcare Delivery System." Cancer Research 83, no. 5_Supplement (March 1, 2023): P3–03–09—P3–03–09. http://dx.doi.org/10.1158/1538-7445.sabcs22-p3-03-09.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Abstract Background: Most cytotoxic drugs are dosed according to body surface area (BSA), yet not all patients receive the full BSA-determined dose. Prior work suggests that dose reduction may occur more frequently in obese patients, likely due to concern about inducing toxicity at high doses. Other factors, such as race/ethnicity, have been suggested to be associated with dosing, yet the factors associated with dose reduction remain poorly understood, with little known about dosing patterns in integrated healthcare delivery systems and how such patterns have changed over time. Methods: We examined chemotherapy dosing in 452 women diagnosed with stage I-IIIA primary breast cancer at Kaiser Permanente Northern California. All study participants were a part of the Pathways Study, diagnosed between 2006-2013, and treated with the common breast cancer regimen, ACT (cyclophosphamide and doxorubicin, followed by paclitaxel). We explored the association between obesity and dose reduction, and further explored other factors in relation to dose reduction, including various sociodemographic characteristics, tumor characteristics, and comorbidities. We assessed dosing using first cycle dose proportion (< 90% expected dose) and average relative dose intensity (ARDI, a metric of dose intensity over the entire course of chemotherapy). Results: Overall, 8% of women received a dose reduction >10% in the first cycle of chemotherapy and 21.2% of patients had an ARDI < 90%. Obesity was a strong predictor of dose reduction, both in the first cycle and across all cycles. In the first cycle, 21.9% of severely obese patients (body mass index, BMI: 35+ kg/m2) were dose reduced, whereas no normal weight patients (BMI: 18.5-< 25 kg/m2) experienced a first cycle dose reduction. Across all cycles, 38.4% of severely obese women had an ARDI < 90%, as compared 12.8% of normal weight women. In logistic regression models adjusted for age, race/ethnicity, and white blood cell count, obese women had 4.1-fold higher odds of receiving a dose reduction of 10% or more over the course of chemotherapy than their normal weight counterparts (95% CI: 1.9, 8.9; p-trend: 0.006). Increasing age was positively associated with dose reduction across the course of chemotherapy, as was the presence of comorbidity. Importantly, dose reduction was less common in later calendar years. Sensitivity analyses revealed that the positive association between obesity and dosing was robust to further adjustment for these other significantly associated factors. Impact: These results offer insight on factors associated with variation in chemotherapy dosing for a common breast cancer treatment regimen. Larger studies are required to evaluate relevance of these findings to other treatment regimens. Further work will be needed to determine whether dose reductions impact breast cancer outcomes. Citation Format: Elizabeth D. Kantor, Kelli O’Connell, Isaac J. Ergas, Emily Valice, Janise M. Roh, Jenna Bhimani, Narre Heon, Jennifer J. Griggs, Jean Lee, Erin J. Bowles, Donna R. Rivera, Tatjana Kolevska, Elisa Bandera, Lawrence H. Kushi. Assessment of Breast Cancer Chemotherapy Dose Reduction in an Integrated Healthcare Delivery System [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P3-03-09.

8

Grant, Shakira J., Milenka Jean-Baptiste, Jiona A. Mills, Shanghong Wang, and Paul Mihas. "“to Represent a Black Point of View”: Willingness of Black Persons with Multiple Myeloma to Participate in Clinical Trials." Blood 142, Supplement 1 (November 28, 2023): 1065. http://dx.doi.org/10.1182/blood-2023-187825.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Background Cancer clinical trials are essential for advancing scientific knowledge and improving patient-centered clinical outcomes, but racial-ethnic diversity is often lacking (Ajewole et al., 2021; Alqazaqi et al., 2022). In multiple myeloma (MM) trials leading to Food and Drug Administration (FDA) approvals, only about 4% of participants are African American (AA)/Black (Kanapuru et al., 2022) despite higher incidence rates in this group. Barriers, like medical mistrust, communication issues, trial location, and eligibility criteria, contribute to underrepresentation (Grant, Jansen, et al., 2022; Grant, Jean-Baptiste, et al., 2022b; a; Kanapuru et al., 2023). Understanding factors influencing participation is critical for recruitment (Sheridan et al., 2020), yet a focus on the willingness of Black persons to participate in clinical trials remains underreported. Therefore, our objective was to understand factors influencing the willingness of AA/Black persons diagnosed with MM to participate in clinical trials. Methods We conducted a descriptive qualitative study between August 2021 and February 2022, recruiting 23 patients diagnosed with MM from a Comprehensive Cancer Center in North Carolina. For comparison, participants were grouped into three types of focus group discussants (FGDs), those with and without prior clinical trial enrollment and one group with a mixture of trial experience. All enrolled participants completed a researcher-captured sociodemographic survey, followed by the remote semi-structured FGD, lasting between 90-120 minutes. We used ATLAS.ti v9 and later v 23.2.1 for project management and to facilitate data analysis using the Sort and Sift, Think and Shift approach (ResearchTalk Inc). Results We conducted six focus groups: three with 13 participants without trial experience, two with 7 participants with prior experience, and one with a mix of trial experience. Participants without trial experience were younger (mean age 61 years, median 65 years, range 40-71) than those with trial experience (mean age 68 years, median 69.5 years, range 55-83). Most participants with trial experience had an associate degree or higher and higher annual pre-tax incomes ($100,000 to $149,999). Participants without experience had varied education levels but significantly lower annual incomes (<$30,000). All recruited participants had health insurance, with only two enrolled participants without trial experience having Medicaid insurance coverage. Factors influencing willingness to participate (Table 1) included: 1) awareness of clinical trials, 2) perceptions about trials, 3) interest in representing AA/Black persons in trials, 4) altruistic motives, and 5) perceived benefits (beneficiaries). Participants with prior trial experience often regarded clinical trials as crucial for their survival, emphasizing the significance of research in benefiting themselves and others. One participant even used the phrase “to represent a Black viewpoint” when explaining their decision to enroll in a clinical trial. While discussing perceptions, participants generally brought up unethical research practices that have affected AA/Black persons. However, they also highlighted the importance of having AA/Black representation in clinical trials. All FGDs emphasized their willingness to participate in future clinical trials, and many showed altruism by viewing it as an opportunity to “pay it forward” and contribute to the greater good, leading to positive feelings and outlooks for some. Additionally, many FGDs highlighted safety concerns for interventional therapies and the need to weigh the benefits of participation in this regard carefully . Conclusion Our study reveals that AA/Black persons with MM are willing to participate in clinical trials, regardless of prior experience, although some may initially have limited awareness of such trials. This underscores the importance of implementing multilevel approaches (individual, interpersonal, healthcare system, and policy) to enhance awareness and influence perceptions. Moving forward, we emphasize the significance of establishing community partnerships to shape educational and outreach efforts, promoting diversity in research participants. Furthermore, additional efforts are needed to ensure equitable participation opportunities for AA/Black individuals within healthcare system interactions.

9

Jongbloed, Elisabeth M., Stefania Stella, Lotte van Bergen, Corine Beaufort, Jean Helmijr, Vanja de Weerd, Frans Erdkamp, et al. "Abstract PO2-14-06: CIRCULATING TUMOR DNA DYNAMICS IN THE FIRST TREATMENT LINE OF THE SONIA TRIAL." Cancer Research 84, no. 9_Supplement (May 2, 2024): PO2–14–06—PO2–14–06. http://dx.doi.org/10.1158/1538-7445.sabcs23-po2-14-06.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Abstract Background and objective: CDK4/6 inhibitors (CDK4/6i) improve the outcome of patients with ER+/HER2- advanced breast cancer when added to endocrine therapy in the first line or second line of treatment. The recently reported SONIA trial shows no difference in progression free survival after two lines of treatment (PFS2), overall survival (OS) or quality of life benefit of CDK4/6i in first-line compared to second-line, while adverse events are substantially higher when CDK4/6i is added in the first-line. However, a subgroup of patients shows early progression on endocrine mono-treatment and not all patients respond equally well to CDK4/6i. This highlights the need for early response markers during the first weeks of treatment to reduce unnecessary toxicity while providing the most optimal care. In this SONIA side study, we aim to investigate whether we could identify patients who will progress rapidly during first line of therapy by using circulating tumor DNA (ctDNA) dynamics. Methods: Blood samples were obtained from patients included in the SONIA trial in both the first line CDK4/6i + aromatase inhibitor (AI) combination arm (arm A) and the first line AI monotherapy arm (arm B) at three time points: before start, after two weeks and after three months of first line treatment. Cell free DNA (cfDNA) was isolated from all samples and subsequently baseline cfDNA was sequenced with the Oncomine™ Breast cfDNA Assay v2 (Thermofisher), a focused NGS panel of 10 genes. Dedicated dPCR assays were used to track an identified driver mutation over time. Results: Blood samples of 332 patients (206 in arm A and 126 in arm B) before start of first line treatment and after two weeks of treatment were obtained. At baseline, in 142 of the 332 (42.7%) patients at least one somatic mutation was detected. In 30 patients two or more mutations were identified, in which case the mutation with the highest variant allele frequency (VAF) was followed over time. The most frequently mutated genes were PIK3CA (102 patients (30.7% of the total included cohort)), TP53 (32 patients (9.6%)), SF3B1 (8 patients (2.4%) and ESR1 (6 patients (1.8%)). The median observed VAF at baseline was 4.1% (IQR: 1.5%-13.1%). Of the 142 patients with detectable ctDNA at baseline, 141 patients and 100 patients, respectively, had blood samples taken after 2 weeks and after 3 months of treatment. After two weeks, the VAF of the tracked mutation was increased in 15.2% (14/92) of the patients in arm A and in 18.4% (9/49) of the patients in arm B. At the same time 40.2% (37/92) of the patients in arm A and 34.7% (17/49) of the patients in arm B had cleared ctDNA. No difference was observed between the arms for both an increase in VAF (P=0.63, Chi-square test) and ctDNA clearance (P=0.52, Chi-square test). After 3 months an increased VAF of the tracked mutation compared to baseline was observed in 6.3% (4/64) of the patients in arm A and 8.3% (3/36) of the patients in arm B. At this timepoint 59.4% (38/64) of the patients in arm A and 61.1% (22/36) of the patients in arm B had cleared ctDNA. No difference was observed between the arms for both ctDNA clearance (P=0.86, Chi-square test) and increase in VAF (P=0.70, Chi-square test) after three months. Conclusions: ctDNA was detected at baseline in almost half of the patients in the SONIA study. Compared to baseline, a decreasing number of patients had an elevation of the VAF of the tracked mutation and an increasing number of patients showed ctDNA clearance from 2 weeks to 3 months after start of treatment. There was no difference between the two arms observed regarding ctDNA dynamics. Interestingly, irrespective of treatment arm, about 1/3rd of patients remained ctDNA-positive even after 3 months of treatment. Associations of these ctDNA data with the clinical outcome data are currently being evaluated and will be presented at the meeting. Citation Format: Elisabeth M Jongbloed, Stefania Stella, Lotte van Bergen, Corine Beaufort, Jean Helmijr, Vanja de Weerd, Frans Erdkamp, Joan Heijns, Yvonne Kamm, Anne-Marie van Riel, Quirine van Rossum-Schornagel, Maurice Jansen, Inge RHM Konings, Gabe Sonke, John WM Martens, Agnes Jager, Saskia M Wilting. CIRCULATING TUMOR DNA DYNAMICS IN THE FIRST TREATMENT LINE OF THE SONIA TRIAL [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl):Abstract nr PO2-14-06.

10

Mout, Nicolette. "Alastair Hamilton,The Family of Love I: Hendrik Niclaes [Bibliotheca Dissidentium, Répertoire des non-conformistes religieux des seizième et dix-septième siècles, édité par André Seguenny en collaboration avec Jean Rott †, 22; Bibliotheca Bibliographica Aureliana 191]. Éditions Valentin Koerner, Baden-Baden/Bouxwiller 2003, 46 ill., 218 pp. isbn 9783873201910. €98. — Alastair Hamilton,The Family of Love II: Hiël (Hendrik Jansen Barrefelt). Addenda to The Family of Love I: Hendrik Niclaes [Bibliotheca Dissidentium, Répertoire des non-conformistes religieux des seizième et dix-septième siècles, fondé par André Seguenny, dirigé par Martin Rothkegel, 29; Bibliotheca Bibliographica Aureliana 235]. Éditions Valentin Koerner, Baden-Baden/Bouxwiller 2013, 49 ill., 234 pp. isbn 9783873207356. €98." Church History and Religious Culture 94, no. 2 (2014): 274–76. http://dx.doi.org/10.1163/18712428-09402010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Jean Jansem":

1

Ivchenkova, Tatiana. "Visage impossible : l’empreinte des totalitarismes et des terreurs sur l’effacement du visage humain dans la peinture moderne et contemporaine occidentale." Electronic Thesis or Diss., Paris 8, 2022. http://www.theses.fr/2022PA080026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

L’objet de cette recherche est d’étudier le phénomène de la disparition du visage humain dans l’art moderne et contemporain occidental, en particulier dans sa dimension politique. L’empreinte des totalitarismes et des terreurs du XXe siècle sur l’effacement du visage a pris une profondeur considérable, ce qu’on découvre dans des œuvres de Kazimir Malevitch, Miklos Bokor, Zoran Music, Safet Zec, Jean Jansem, Mikhaïl Roginsky et Francine Mayran. La face gommée de l’homme opprimé, déshumanisé, privé de personnalité représente le portrait collectif d’une société souffrante. Dans ce travail nous analysons aussi l’opposition que ce phénomène plastique exprime face à l’art officiel des régimes totalitaires, dans lequel la face humaine reste très réaliste. Enfin, nous révélons le rôle du visage effacé dans la construction de la mémoire collective de la société, cette substance fragile qui subit souvent des déformations et connaît des effacements
This research studies the phenomenon of the disappearance of the human face in modern and contemporary Western art, particularly in its political dimension. The footprint of the totalitarianisms and terrors of the 20th century on facial erasure has taken on a considerable depth, which is discovered in works by Kazimir Malevich, Miklos Bokor, Zoran Music, Safet Zec, Jean Jansem, Mikhail Roginsky and Francine Mayran. The gutted face of the oppressed, dehumanized, personality-deprived man represents the collective portrait of a suffering society. In this work we also analyze the opposition that this plastic phenomenon expresses to the official art of totalitarian regimes, in which the human face remains very realistic. Finally, we reveal the role of the erased face in the construction of the collective memory of society, this fragile substance that often undergoes deformations and deletions

2

Jansen, Jean David [Verfasser]. "Zur Behandlung einer gelöschten limited company als Restgesellschaft in der Bundesrepublik Deutschland / Jean David Jansen." Baden-Baden : Nomos Verlagsgesellschaft mbH & Co. KG, 2015. http://d-nb.info/1106339827/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ng, Chi-mei. "Re-reading Jane Eyre and Wide Sargasso Sea." Click to view the E-thesis via HKUTO, 1996. http://sunzi.lib.hku.hk/hkuto/record/B42574493.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Postemsky, Diana. "Through the looking-glass reading and reflecting from Wide Sargasso Sea to Jane Eyre /." Diss., Connect to the thesis, 2003. http://hdl.handle.net/10066/647.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lorphelin, Elsa. "Intertextualité, interdiscursivité et autorité dans les nouvelles de Jean Rhys, Janet Frame et Anita Desai." Thesis, Sorbonne université, 2020. http://www.theses.fr/2020SORUL113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Couvrant la quasi-totalité du XXe siècle, les écrits de Jean Rhys, Janet Frame et Anita Desai témoignent de la relation de la Caraïbe, de la Nouvelle-Zélande et de l’Inde à l’Empire britannique. Cette thèse s’intéresse en particulier aux nouvelles de trois auteures plus connues en tant que romancières, car, genre marginal et fragmentaire, la nouvelle fait écho à un certain nombre de problématique postcoloniales, modernistes et postmodernes. Il s’agira en l’occurrence de s’attarder sur la question de la voix et du discours, et notamment sur la façon dont l’omniprésence de discours idéologiques, politiques, sociaux, se trouve doublé de la présence d’un réseau intertextuel mis en œuvre par les auteures. La récupération de la voix d’autrui, et en particulier du canon littéraire occidental, dans un contexte où l’autorité féminine et postcoloniale est des plus précaires, pose la question de l’autorité littéraire. On observera que sous la plume de ces auteures, la nouvelle devient plus que jamais un genre hybride, plurivocal, aux contours fuyants, dont le genre est sans cesse requalifié. Loin du monolithisme du roman, la nouvelle apparaît comme un espace de liberté et de création où l’autorité est sans cesse réaffirmée tout autant que diffractée, et où les présences auctoriales tout à la fois s’effacent et se manifestent. Véritables lieux d’une mise en scène de la figure de l’Auteur, la nouvelle et le recueil déjouent les limites du genre, tissant un réseau discursif et intertextuel complexe, où Jean Rhys, Janet Frame et Anita Desai élaborent une esthétique de la voix
The literary production of Jean Rhys, Janet Frame, and Anita Desai, which covers nearly all the twentieth century, testifies to the relationship between the Caribbean, New-Zealand, India and the British Empire. Even though Rhys, Frame and Desai are mostly known as novelists, this thesis dwells on their short stories. As a marginal and fragmentary genre, the short story echoes a variety of issues related to Postcolonialism, Modernism and Postmodernism. My issue is the study of the themes of the voice and of discourse, and especially of the way in which the omnipresence of ideological, political and social discourses is further complexified by the presence of intertextuality. The use of alien voices, borrowed notably from the western literary canon, poses the question of literary authority – especially in a context where postcolonial and feminine authority is so precarious. We shall observe that, in these authors’ short stories, the genre becomes hybrid, plurivocal, harder to define, which entails its requalification. Far from the monolithic nature of the novel, the short story appears as a space of liberty and creation where authority is both tampered with and constantly reaffirmed, and where authorial presences in turn appear and disappear. As places where the figure of the Author is continuously staged, the short story and the collection of short stories redefine the limits of the genre by weaving an intricate discursive and intertextual fabric where Jean Rhys, Janet Frame and Anita Desai work towards the elaboration of an aesthetic of the voice

6

Isaksson, Terese. "Jane, hennes älskade och hans hustru : En läsdidaktisk litteraturanalys av Charlotte Brontës Jane Eyre och Jean Rhys Sargassohavet." Thesis, Uppsala universitet, Litteraturvetenskapliga institutionen, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-167360.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Rantonen, Nadja. "Feminist Struggles for Identity in Charlotte Brontë’s Jane Eyre and Jean Rhys’s Wide Sargasso Sea." Thesis, Mittuniversitetet, Avdelningen för humaniora, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:miun:diva-35671.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Grizenko, Marisa Katherine. "Two drunk ladies : the modernist drunk narrative and the female alcoholic in the fiction of Jean Rhys and Jane Bowles." Thesis, University of British Columbia, 2012. http://hdl.handle.net/2429/43579.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

This thesis takes as its starting point the culturally potent figure of the alcoholic modernist, who, heroically facing existential despair, is predominantly gendered as male. Pointing to the absence of the female alcoholic as writer and subject in critical accounts of modernism, I argue that a drunk narrative, written by and about women, exists alongside the prototypical male narrative, and call for a re-examination of the modernist writer‘s relationship to alcohol. Exploring the historical and cultural contexts that have contributed to the gendering of alcoholism and drinking practices in general, as well as the gendering of the modernist artist in particular, I then consider how writers Jean Rhys and Jane Bowles articulate their vision of the drinking woman. Rhys‘s 1939 novel Good Morning, Midnight sees protagonist Sasha Jansen employing the discursive category of female drunk as a tool of resistance in Paris‘ patriarchal and capitalist urban economy. I situate her as tactically capitalizing, in a de Certeauan fashion, on her abjection and visibility. Bowles‘s 1943 novel Two Serious Ladies extends Sasha‘s individual drunkenness to an overarching, abstracted drunkenness that reflects the worldview of the text. I trace how drunkenness functions thematically and linguistically in the two female protagonists‘ existential quests. While identifying existing gaps in the scholarship, I also hope to gesture to rich areas of potential research and model a reading practice that explores female interventions in the male modernist drunk narrative.

9

Kiam, Jane Jean [Verfasser], Axel [Akademischer Betreuer] Schulte, Axel Gutachter] Schulte, and Eva [Gutachter] [Besada-Portas. "Al-Based Mission Planning for High-Altitude Pseudo-Satellites in Time-Varying Environments / Jane Jean Kiam ; Gutachter: Axel Schulte, Eva Besada-Portas ; Akademischer Betreuer: Axel Schulte ; Universität der Bundeswehr München, Fakultät für Luft- und Raumfahrttechnik." Neubiberg : Universitätsbibliothek der Universität der Bundeswehr München, 2019. http://nbn-resolving.de/urn:nbn:de:bvb:706-7008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Kiam, Jane Jean [Verfasser], Axel Akademischer Betreuer] Schulte, Axel [Gutachter] Schulte, and Eva [Gutachter] [Besada-Portas. "Al-Based Mission Planning for High-Altitude Pseudo-Satellites in Time-Varying Environments / Jane Jean Kiam ; Gutachter: Axel Schulte, Eva Besada-Portas ; Akademischer Betreuer: Axel Schulte ; Universität der Bundeswehr München, Fakultät für Luft- und Raumfahrttechnik." Neubiberg : Universitätsbibliothek der Universität der Bundeswehr München, 2019. http://d-nb.info/1224617231/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Jean Jansem":

1

Royère, Jean. Jansen ... présente Jean Royère, 1902-1981: Créateur et décorateur : du mercredi 17 avril au lundi 20 mai 1985. Paris: A. de Heeckeren, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

O'Rourke, James L. Sex, lies, and autobiography: The ethics of confession. Charlottesville: University of Virginia Press, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Nazar, Hina. Enlightened sentiments: Judgment and autonomy in the age of sensibility. New York: Fordham University Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Lohsse, Sebastian, Reiner Schulze, and Dirk Staudenmayer, eds. Smart Products. Nomos Verlagsgesellschaft mbH & Co. KG, 2022. http://dx.doi.org/10.5771/9783748929772.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Some aspects of smart products have been regulated by the Digital Contracts Directives adopted in 2019. However, smart products not only are an important subject for contract law but also for product liability law. For contract law the main questions to be addressed are how smart products fit into existing concepts of contract law and, moreover, how they can be used in legal and commercial practice; for product liability law is analysed how the Product Liability Directive can meet the challenges posed by smart products. The 6th Münster Colloquium provided a forum for in-depth discussion of these and related questions between renowned experts on digital law as well as representatives from politics as well as industry and consumer stakeholders. With contributions by Georg Borges, Jean-Sébastien Borghetti, Isabell Conrad, Susanne Dehmel, Evelyne Gebhardt, Jutta Gurkmann, André Janssen, Bernhard A. Koch, Sebastian Lohsse, Teresa Rodríguez de las Heras Ballell, Gerhard Schomburg, Hans Schulte-Nölke, Reiner Schulze, Karin Sein, Dirk Staudenmayer, Gerhard Wagner, Christiane Wendehorst and Axel Voss.

5

Ellmann, Maud. Sylvia Townsend Warner. Oxford University Press, 2016. http://dx.doi.org/10.1093/oxfordhb/9780199935338.013.31.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

This article reviews some important recent contributions to the belated recovery of the work of English novelist and poet Sylvia Townsend Warner. Described by Eleanor Perényi as “feminist, Marxist, historical novelist, social comedian, teller of fairy tales,” Warner has received scant critical attention, in stark contrast to her remarkable productivity. Warner published thirty-six books during her lifetime, in addition to four posthumous collections of poems and short stories; at least 154 short stories published in theNew Yorker; her diary, published by Chatto and Windus in 1994; several volumes of correspondence; a revised and expanded edition of her poems; her translation of Marcel Proust’s critical writings inBy Way of Sainte-Beuve; and a volume of previously uncollected writings,With the Hunted, which includes many short pieces previously published in theJournal of the Sylvia Townsend Warner Society. The present article looks at key critical responses to Warner’s work by such writers as Jan Montefiore, Jane Marcus, Gillian Beer, Jean-Jacques Lecercle, and Mary Jacobs.

6

Duncan, Joyce D. Shapers of the Great Debate on Women’s Rights. Greenwood Publishing Group, Inc., 2008. http://dx.doi.org/10.5040/9798216014249.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

The three waves of feminism are explored through the lives of the women who made history in bringing women’s issues to the forefront of American society. Many early feminists supported not only women’s rights, but also rights of slaves and contributed to the passing of the Thirteenth Amendment, granting emancipation to slaves. They continued to work towards women’s suffrage and were hopeful the Fourteenth Amendment would provide universal suffrage. However, women were not granted suffrage until the passing of the Nineteenth Amendment, nearly fifty years later. It was women’s fundamental need for independence and an identity of their own, separate from that of men, which thrust the women’s movement forward and continues to propel it today. Many notable women, such as Susan B. Anthony, Elizabeth Cady Stanton, Billie Jean King, Betty Friedan, Helen Gurley Brown, Jane Fonda, and Sandra Day O’Connor, are included in this history of the women’s movement in America. The biographical entries cite works for further reading, and the volume closes with a bibliography. The Shapers of the Great Debate series takes a biographical approach to history, following the premise that people make history in the circumstances in which they find themselves. Each volume in this series examines the lives and experiences of the individuals involved in a particular debate through both major and minor biographies.

7

Ashtor, Gila. Homo Psyche. Fordham University Press, 2021. http://dx.doi.org/10.5422/fordham/9780823294169.001.0001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

An analysis that focuses on the metapsychological dimension of queer theorizations will demonstrate why, in spite of how bold and emancipatory key queer formulations might initially seem, the field maintains an uninterrogated reliance on erotophobic psychological conventions that ultimately reproduces an erotophobic relationship to sexuality. Homo Psyche introduces metapsychology as a new dimension of analysis that zeroes in on the underlying psychological assumptions that determine contemporary critical thought. Such an intervention deepens current debates about the future of queer studies by demonstrating how the field’s systematic neglect of metapsychology as a necessary and independent realm of ideology ultimately enforces the complicity of queer studies with psychological conventions that are fundamentally erotophobic and therefore inimical to queer theory’s radical and ethical project. Homo Psyche therefore introduces a break with the current configuration of traditional psychoanalysis as the presumptive and undisputed foundation for radical psycho-sexual theorizations. In order to elaborate a critical alternative, the French theoretician Jean Laplanche (1924–2012) will be introduced. In order to rigorously articulate and defend the centrality of sexuality to psychic life, Laplanche insisted on “new foundations for psychoanalysis” that radically departed from existing Freudian and Lacanian models of the mind. This study conducts a purposive survey of six major theoretical concepts, through the lens of six eminent individual critics who represent exemplary, influential, and authoritative developments of them: Eve Sedgwick on “hermeneutics,” Leo Bersani on “sex,” Jane Gallop on “violation,” Lee Edelman on “radicalism,” Judith Butler on “gender,” and Lauren Berlant on “relationality.”

Book chapters on the topic "Jean Jansem":

1

Plasa, Carl. "The Creole is of Course the Important One’: Rewriting Jane Eyre." In Jean Rhys, 38–64. London: Macmillan Education UK, 2001. http://dx.doi.org/10.1057/978-1-137-22186-5_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Makoni, Sinfree, Anna Kaiper-Marquez, and Lorato Mokwena. "Conversation with Jean Comaroff and Jane Anna Gordon." In The Routledge Handbook of Language and the Global South/s, 71–92. London: Routledge, 2022. http://dx.doi.org/10.4324/9781003007074-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hilmes, Carola, and Gabriele Rohowski. "Schriften aus dem Nachlass: Die Legende von der Reue des Bischofs Jehan d’Aigremont von St. Anne in Rouen (1924; 2003), Jans muß sterben (1925; 2000), Der gerechte Richter (1957; 1990)." In Anna Seghers-Handbuch, 171–75. Stuttgart: J.B. Metzler, 2020. http://dx.doi.org/10.1007/978-3-476-05665-8_29.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Howard, Patricia. "The Piccinni War: First Shots (1776–1777)." In Gluck, 164–74. Oxford University PressOxford, 1995. http://dx.doi.org/10.1093/oso/9780198163855.003.0018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Abstract In July 1776, Gluck’s Parisian friends planned to honour him by commissioning a marble copy of Houdon’s bust, to be placed in the Opéra beside those of Lully and Rameau. The tribute was intended to mark Gluck’s acceptance as a French composer of classic status. A subscription was set up by the cellist Jean-Baptiste Janson (or Jannson) and c by six of Gluck’s colleagues and friends: (in order of signing) Gossec, Du Roullet, Larrivée, Le Due (director of the Concert spirituel), Berton, and Le Gros.

5

Gutstein, Dan. "Intermission Number Two." In Poor Gal, 96–104. University Press of Mississippi, 2023. http://dx.doi.org/10.14325/mississippi/9781496849342.003.0009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

The second of three “intermissions,” this chapter explores relationships between the “Liza Jane” family of songs and American literary classics. While “Liza Jane” songs do not seem to have origins in works such as Uncle Tom’s Cabin, the opposite is quite another matter. Both the Liza Jane character and song lyrics do appear in major fictional pieces, such as Charles Chesnutt’s short story “The Wife of His Youth,” Jean Toomer’s novel Cane, and Margaret Walker’s novel Jubilee. Notably, Margaret Walker presents lyrics for “Steal Miss Liza,” a ring game played together by Black and white children. These three authors demonstrate considerable perception as to the origins of the songs, in linking their fictional works with the “Liza Jane” family.

6

Ross, Bruce M. "Developmental Memory Theories." In Remembering the Personal Past, 133–49. Oxford University PressNew York, NY, 1992. http://dx.doi.org/10.1093/oso/9780195068948.003.0007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Abstract Theoretical ideas about development of children’s personal memories are by no means monopolized by psychoanalysis and related theories. As to the part such memories play in the normal socialization of the child, questions arise that scarcely occur when psychotherapy is the goal. In nonanalytical approaches, however, concepts descriptive of memory functioning tend to be fragmented and less central to overarching theory. This chapter samples concepts from three important theorists independent of the psychoanalytic tradition: James Mark Baldwin, Jean Piaget, and Pierre Janet.

7

Mills, Jean. "Out-takes from Upstarts: Virginia Woolf, Jane Ellen Harrison, and the Heritage of Dissent, or, “There She Wasn’t?”." In Virginia Woolf and Heritage. Liverpool University Press, 2018. http://dx.doi.org/10.5949/liverpool/9781942954422.003.0005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Jean Mills uses Virginia Woolf’s legacy and literature to process the work and impact of two important women in her life, the Virginia Woolf scholar, Jane Marcus, and her own mother, following their deaths. In her attempts to preserve and champion the memory of the two women, Mills acknowledges Woolf’s own participation in the act of writing women into obscurity and refers to Jane Harrison’s title of ‘J.H’ in A Room of One’s Own. Mills argues that not using the scholar’s full name contributes to Harrison’s erasure and reveals Woolf’s act of distancing between herself and her female role models. While Mills attributes Woolf’s sense of isolation from her academic audience as a result of distancing and alienation, she acknowledges that many of Woolf’s narratives privileged women’s history and experience, and observes that any presence of ambivalence can be utilised as a necessary tool to foreground the need for the recognition of women in activism and political thought.

8

Paradis, Carole, and Renée Béland. "Syllabic Constraints and Constraint Conflicts in Loanword Adaptations, Aphasic Speech, and Children’s Errors." In Phonetics, Phonology, and Cognition, 191–225. Oxford University PressOxford, 2002. http://dx.doi.org/10.1093/oso/9780198299837.003.0009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Abstract In a longitudinal case study, Beland and Paradis (1997) compared the syllabic errors-defined as segment insertion and deletion (as opposed toWe would like to thank the audience at the ‘Current Trends in Phonology II’ Conference, held at the Abbey of Royaumont near Paris in 1998, where a preliminary version of this chapter was presented. We are particularly grateful to Steve Anderson, John Goldsmith, Janet Pierrehumbert, Jean-Frarn;:ois Prunet, and Annie Rialland for their illuminating comments and challenging questions. We are also deeply indebted to Isabelle McClish and Joel Macoir for their work with the second aphasic patient of our study, to Claudine Blouin, Andre Courcy, Yannique Laplame, and Myriam Baba’i for their work with the children of our study, and to Darlene LaCharite for her feedback on this version of the article vis-a-vis both substance and exposition. We acknowledge SSHRC grants 4ro-97-r446 (C.P.) and 4ro-96-r467 (R.B.) and FCAR grant 98-ER-2305 (C.P. and R.B.).

9

Smith, Steven C. "Indian Summer." In Music by Max Steiner, 329–44. Oxford University Press, 2020. http://dx.doi.org/10.1093/oso/9780190623272.003.0022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

This chapter depicts Steiner at the apex of his powers, just before the collapse of the Hollywood studio system. Between 1947 and 1948 Steiner composed several brilliant scores and at least three of his finest: for John Huston’s The Treasure of the Sierra Madre, Jean Negulesco’s Johnny Belinda (which earned Jane Wyman a Best Actress Oscar), and Adventures of Don Juan, starring Errol Flynn in his last big-budget swashbuckler. Don Juan demonstrates the transformative power of film music: during production, the alcoholic Flynn could barely stand. But Steiner’s exuberant, lyrical, and witty score convinced audiences that Flynn remained a larger-than-life hero. In 1947, Steiner married Lee Blair, who would remain a devoted companion to the end of Max’s life. Steiner also lavished son Ronald with expensive gifts—giving the boy everything except what he wanted most: time with his father.

10

Curtis, Cathy. "A Taste of Success." In Alive Still, 59–70. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780190908812.003.0005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

In 1956, Nell joined the new Poindexter Gallery. Reviewers praised her first show. The following year, she was awarded a residency at Yaddo (the artists’ colony in Saratoga Springs, New York), meeting poets Jane Mayhall and May Swenson. Afterward, she traveled to Mexico City and Oaxaca, where she worked at night by the light of an oil lamp. On her return, she spent several weeks at the MacDowell Colony in New Hampshire, followed by another stay at Yaddo in December, when her fellow residents were poets Barbara Guest and Jean Garrigue. Nell spent the summer of 1958 in a rented studio in Gloucester. It was there that ARTnews writer Lawrence Campbell visited her to write a major piece about her work on Harbor and Green Cloth, illustrated with photographs by her friend Rudy Burckhardt. A second version of this painting was purchased by the Whitney Museum of American Art.

Conference papers on the topic "Jean Jansem":

1

Tomanek, Katrin, Joachim Wermter, and Udo Hahn. "Efficient annotation with the Jena ANnotation Environment (JANE)." In the Linguistic Annotation Workshop. Morristown, NJ, USA: Association for Computational Linguistics, 2007. http://dx.doi.org/10.3115/1642059.1642061.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Contreras, Francisco Guerrero. "DE ESTACIONES Y ENTORNOS A ESPACIOS DE INTERFASE MULTIMODAL El caso de la Línea 1 del Tren Ligero de Guadalajara, México." In Seminario Internacional de Investigación en Urbanismo. Bogotá: Universidad Piloto de Colombia, 2022. http://dx.doi.org/10.5821/siiu.10016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Recently, the emerging interest in the study of public space and its urban dimensions associated with mobility has been enlivened and enriched; from Jane Jacobs (1961), Jean Gehl (2010) and others, to the most recent planning models such as the "superblock" or the "complete street" and tactical urbanism as an intentional guide to the planning of public space in cities. This research seeks to make clear that both, public space and urban mobility, cannot be confronted as two concepts, but rather, it suggests to face them as a new model to understand what happens between them when they coincide in a tempo-spatial point in the territory and follow the pattern of modal interchange making them potential elements of attraction, exchange, quality and transition around the public transport stations of the L1 of the Urban Electric Train in the Metropolitan Area of Guadalajara, México. Keywords: public space, urban mobility, multimodal interface, stations. Topic: Public space and urban project in the contemporary metropolis. Recientemente se ha avivado y enriquecido el interés emergente en el estudio del espacio público y sus dimensiones urbanas asociadas a la movilidad; desde Jane Jacobs (1961), Jean Gehl (2010), Wojnarowska (2016), Duivenvoorden, Hartmann, Brinkhuijsen & Hesselmans, (2021) y otros, hasta los más recientes modelos de planificación como la “supermanzana” o la “calle completa” y el urbanismo táctico a manera de una guía intencionada sobre la planificación del espacio público en las ciudades. Esta investigación busca dejar en claro que tanto espacio público como movilidad urbana no se pude afrontar como dos conceptos, sino más bien, sugiere afrontarse como un nuevo modelo para entender lo que sucede entre éstos dos cuando coinciden de manera tempo-espacial en un punto del territorio y siguen la pauta del intercambio modal haciéndolos elementos potenciales de atracción, intercambio, calidad y transición para su futuro análisis en torno a las estaciones de la L1 del Tren Eléctrico Urbano en el Área Metropolitana de Guadalajara, México. Palabras clave: espacio público, movilidad urbana, interfase multimodal, estaciones. Bloque temático: Espacio público y proyecto urbano en la metrópolis contemporánea.